NKGen Biotech, Inc. announced it has entered Securities Purchase Agreements with AJB Capital Investments LLC,Sandia Investment Management LP, Diametric True Alpha Market Neutral Master Fund LP and Diametric True Alpha Enhanced Market Neutral Master Fund and issued 12% Unsecured Convertible promissory note for a principal amount $550,000, at a purchase price of $500,000 on April 1, 2024. The promissory note bears a coupon rate of 12% and matures on April 1, 2025. The notes can be converted into shares of the Company?s common stock at any time from the issue date to the AJB Maturity Date at a conversion price of $2.00.pursuant to the agreement company also issued Common Stock Purchase Warrants to purchase up to 550,000 shares of Common Stock at an exercise price of $2.00 per share for a period of five years from the issue date.